Theravance Biopharma, Inc. - Ordinary Shares (TBPH): Price and Financial Metrics


Theravance Biopharma, Inc. - Ordinary Shares (TBPH): $10.62

-0.03 (-0.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TBPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TBPH POWR Grades

  • Growth is the dimension where TBPH ranks best; there it ranks ahead of 96.49% of US stocks.
  • TBPH's strongest trending metric is Quality; it's been moving up over the last 177 days.
  • TBPH ranks lowest in Stability; there it ranks in the 33rd percentile.

TBPH Stock Summary

  • TBPH's current price/earnings ratio is 0.84, which is higher than only 0.45% of US stocks with positive earnings.
  • With a year-over-year growth in debt of -92.24%, THERAVANCE BIOPHARMA INC's debt growth rate surpasses just 1.56% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for TBPH comes in at 101.68% -- higher than that of 98.24% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to THERAVANCE BIOPHARMA INC are IDR, ATAI, ROIV, NRGV, and IONQ.
  • TBPH's SEC filings can be seen here. And to visit THERAVANCE BIOPHARMA INC's official web site, go to www.theravance.com.

TBPH Valuation Summary

  • TBPH's price/earnings ratio is 0.8; this is 96.38% lower than that of the median Healthcare stock.
  • Over the past 106 months, TBPH's price/sales ratio has gone down 3263.5.

Below are key valuation metrics over time for TBPH.

Stock Date P/S P/B P/E EV/EBIT
TBPH 2023-01-30 13.9 1.5 0.8 0.3
TBPH 2023-01-27 14.2 1.5 0.9 0.3
TBPH 2023-01-26 13.9 1.5 0.8 0.3
TBPH 2023-01-25 14.2 1.5 0.9 0.3
TBPH 2023-01-24 14.3 1.5 0.9 0.3
TBPH 2023-01-23 14.2 1.5 0.9 0.3

TBPH Growth Metrics

    The 2 year net cashflow from operations growth rate now stands at 22.65%.
  • Its 5 year net income to common stockholders growth rate is now at -15.47%.
  • Its 2 year revenue growth rate is now at -38.31%.
TBPH's revenue has moved down $12,515,000 over the prior 15 months.

The table below shows TBPH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 51.643 -105.37 850.46
2022-06-30 52.386 -128.679 -101.479
2022-03-31 54.25 -164.062 -145.693
2021-12-31 55.311 -207.858 -199.426
2021-09-30 59.095 -230.349 -225.826
2021-06-30 64.158 -261.934 -264.161

TBPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TBPH has a Quality Grade of D, ranking ahead of 23.9% of graded US stocks.
  • TBPH's asset turnover comes in at 0.144 -- ranking 228th of 682 Pharmaceutical Products stocks.
  • AVTX, SUPN, and PTCT are the stocks whose asset turnover ratios are most correlated with TBPH.

The table below shows TBPH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.144 1 -0.253
2021-03-31 0.138 1 -0.250
2020-12-31 0.134 1 -0.257
2020-09-30 0.158 1 -0.273
2020-06-30 0.152 1 -0.285
2020-03-31 0.180 1 -0.288

TBPH Price Target

For more insight on analysts targets of TBPH, see our TBPH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.38 Average Broker Recommendation 1.94 (Hold)

TBPH Stock Price Chart Interactive Chart >

Price chart for TBPH

TBPH Price/Volume Stats

Current price $10.62 52-week high $11.83
Prev. close $10.65 52-week low $7.53
Day low $10.55 Volume 247,500
Day high $10.79 Avg. volume 436,717
50-day MA $10.88 Dividend yield N/A
200-day MA $9.85 Market Cap 715.43M

Theravance Biopharma, Inc. - Ordinary Shares (TBPH) Company Bio


Theravance Biopharma, Inc. engages in the research and development activities focusing on the diseases of the lung and gastrointestinal tract, and infectious diseases, as well as on the acute care setting markets. The company was founded in 2013 and is based in George Town, the Cayman Islands.


TBPH Latest News Stream


Event/Time News Detail
Loading, please wait...

TBPH Latest Social Stream


Loading social stream, please wait...

View Full TBPH Social Stream

Latest TBPH News From Around the Web

Below are the latest news stories about THERAVANCE BIOPHARMA INC that investors may wish to consider to help them evaluate TBPH as an investment opportunity.

Theravance Biopharma, Inc. Highlights 2022 Accomplishments and 2023 Key Targets

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced its 2022 Accomplishments and 2023 Key Targets.

Yahoo | January 9, 2023

Shareholders in Theravance Biopharma (NASDAQ:TBPH) are in the red if they invested five years ago

While not a mind-blowing move, it is good to see that the Theravance Biopharma, Inc. ( NASDAQ:TBPH ) share price has...

Yahoo | December 25, 2022

Why Is Theravance Bio (TBPH) Up 1.6% Since Last Earnings Report?

Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 7, 2022

Theravance Biopharma, Inc. Announces Final Results of Tender Offer

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the final results of its Dutch auction tender offer (the "Offer") to purchase up to $95 million of its ordinary shares, par value $0.00001 per share (the "Shares"), which expired at midnight, New York City time, at the end of the day on November 17, 2022.

Yahoo | November 22, 2022

Theravance Biopharma, Inc. Announces Preliminary Results of Tender Offer

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the preliminary results of its Dutch auction tender offer (the "Offer") to purchase up to $95 million of its ordinary shares, par value $0.00001 per share (the "Shares"), which expired at midnight, New York City time, at the end of the day on November 17, 2022.

Yahoo | November 18, 2022

Read More 'TBPH' Stories Here

TBPH Price Returns

1-mo -5.18%
3-mo -2.57%
6-mo 12.26%
1-year 18.79%
3-year -65.35%
5-year -61.17%
YTD -5.35%
2022 1.54%
2021 -37.82%
2020 -31.36%
2019 1.17%
2018 -8.25%

Continue Researching TBPH

Here are a few links from around the web to help you further your research on Theravance Biopharma Inc's stock as an investment opportunity:

Theravance Biopharma Inc (TBPH) Stock Price | Nasdaq
Theravance Biopharma Inc (TBPH) Stock Quote, History and News - Yahoo Finance
Theravance Biopharma Inc (TBPH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8517 seconds.